|
Enteropathy-Associated T-Cell Lymphoma
|
C15.604.515.569.480.750.399 |
|
|
Phalloidine
|
D010590 |
[Very toxic polypeptide isolated mainly from AMANITA phalloides (Agaricaceae) or death cup; causes fatal liver, kidney and CNS damage in mushroom poisoning; used in the study of liver damage.
] |
|
Phantom Limb
|
D010591 |
[Perception of painful and nonpainful phantom sensations that occur following the complete or partial loss of a limb. The majority of individuals with an amputated extremity will experience the impression that the limb is still present, and in many cases, painful. (From Neurol Clin 1998 Nov;16(4):919-36; Brain 1998 Sep;121(Pt 9):1603-30)
] |
|
Pipecuronium
|
D03.383.606.760 |
|
|
Pharmaceutic Aids
|
D010592 |
[Substances which are of little or no therapeutic value, but are necessary in the manufacture, compounding, storage, etc., of pharmaceutical preparations or drug dosage forms. They include SOLVENTS, diluting agents, and suspending agents, and emulsifying agents. Also, ANTIOXIDANTS; PRESERVATIVES, PHARMACEUTICAL; COLORING AGENTS; FLAVORING AGENTS; VEHICLES; EXCIPIENTS; OINTMENT BASES.
] |
|
Pharmaceutical Services
|
D010593 |
[Total pharmaceutical services provided by qualified PHARMACISTS. In addition to the preparation and distribution of medical products, they may include consultative services provided to agencies and institutions which do not have a qualified pharmacist.
, A pharmacy service model advocated by the pharmacy profession and approved by legislatures in many states and countries. This model expands the role of PHARMACISTS with additional training (CLINICAL PHARMACISTS) in a patient-centered evidence-based medication management program based on collaboration with physicians and patients.
] |
|
Pharmacies
|
D010594 |
[Facilities for the preparation and dispensing of drugs.
] |
|
Ethics, Business
|
K01.752.566.479.161 |
|
|
Uncertainty
|
E05.318.740.600.900 |
|
|
Pharmacists
|
D010595 |
[Those persons legally qualified by education and training to engage in the practice of pharmacy.
, Pharmacists with clinical training to provide patient-centered evidence-based PHARMACEUTICAL CARE. Clinical pharmacists assist with the design, implementation, monitoring, and modification of the patient's drug treatment.
] |
|
Nurse Administrators
|
M01.526.485.650.580 |
|
|
Nurses
|
M01.526.485.650 |
|
|
Pharmacy Technicians
|
D010596 |
[Persons who perform certain functions under the supervision of a pharmacist.
] |
|
Lingual Nerve Injuries
|
C26.915.300.400.825.500 |
|
|
Trigeminal Nerve Injuries
|
C26.915.300.400.825 |
|
|
Pipemidic Acid
|
D03.383.606.765 |
|
|
Myometrium
|
A10.690.467.500 |
|
|
Ethics Committees
|
K01.752.566.479.147 |
|
|
Inositol Polyphosphate 5-Phosphatases
|
D08.811.277.352.650.624.500 |
|
|
Reduced Folate Carrier Protein
|
D23.050.705.552.600.663 |
|
